BlackRock Advisors’s Bristol-Myers Squibb BMY Stock Holding History

BlackRock Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$210M	Sell	3,585,644 -361,520	-9%	-$19.8M	0.21%	113
2016 Q3	$213M	Buy	3,947,164 +302,339	+8%	+$19.4M	0.22%	114
2016 Q2	$268M	Sell	3,644,825 -2,960,943	-45%	-$209M	0.27%	90
2016 Q1	$422M	Sell	6,605,768 -1,309,340	-17%	-$82.6M	0.44%	52
2015 Q4	$544M	Sell	7,915,108 -1,757,657	-18%	-$116M	0.58%	35
2015 Q3	$573M	Sell	9,672,765 -2,771,619	-22%	-$176M	0.61%	30
2015 Q2	$828M	Sell	12,444,384 -1,662,527	-12%	-$110M	0.86%	17
2015 Q1	$910M	Buy	14,106,911 +677,292	+5%	+$42.4M	0.93%	15
2014 Q4	$793M	Sell	13,429,619 -857,309	-6%	-$48.3M	0.8%	24
2014 Q3	$731M	Sell	14,286,928 -1,129,546	-7%	-$56.4M	0.73%	28
2014 Q2	$748M	Sell	15,416,474 -77,146	-0.5%	-$3.8M	0.71%	32
2014 Q1	$805M	Buy	15,493,620 +29,349	+0.2%	+$1.56M	0.79%	22
2013 Q4	$822M	Sell	15,464,271 -1,587,225	-9%	-$80.9M	0.79%	23
2013 Q3	$789M	Buy	17,051,496 +121,361	+0.7%	+$5.33M	0.79%	16
2013 Q2	$757M	Buy	+16,930,135	New	+$735M	0.79%	19

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock Advisors's BMY Position: Q4 2016 in Review

BlackRock Advisors reduced its Bristol-Myers Squibb (BMY) stake by 9.2% in Q4 2016, selling an estimated $19.8M and leaving 3,585,644 shares worth $210M. The position accounts for 0.21% of the portfolio, ranked #113.

BlackRock Advisors first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $910M in Q1 2015. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

BlackRock Advisors held 3,585,644 shares of Bristol-Myers Squibb worth $210M as of Q4 2016.
BlackRock Advisors sold 361,520 Bristol-Myers Squibb shares in Q4 2016, an estimated $19.8M.
Bristol-Myers Squibb made up 0.21% of BlackRock Advisors's portfolio in Q4 2016, its #113 holding.
BlackRock Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Bristol-Myers Squibb position peaked at $910M in Q1 2015.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.